S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 184 SEK -4.66%
Market Cap: 1.7B SEK

Stille AB
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Stille AB
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Stille AB
STO:STIL
Total Equity
kr692.8m
CAGR 3-Years
56%
CAGR 5-Years
45%
CAGR 10-Years
31%
Elekta AB (publ)
STO:EKTA B
Total Equity
kr8.4B
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Total Equity
kr4.3B
CAGR 3-Years
0%
CAGR 5-Years
60%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Total Equity
kr851.5m
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
18%
Getinge AB
STO:GETI B
Total Equity
kr33B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Total Equity
kr8.3B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
N/A
No Stocks Found

Stille AB
Glance View

Market Cap
1.7B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
198.83 SEK
Undervaluation 7%
Intrinsic Value
Price
S

See Also

What is Stille AB's Total Equity?
Total Equity
692.8m SEK

Based on the financial report for Sep 30, 2025, Stille AB's Total Equity amounts to 692.8m SEK.

What is Stille AB's Total Equity growth rate?
Total Equity CAGR 10Y
31%

Over the last year, the Total Equity growth was 3%. The average annual Total Equity growth rates for Stille AB have been 56% over the past three years , 45% over the past five years , and 31% over the past ten years .

Back to Top